ŠERÝ, Omar, Lýdia HLINECKÁ, Vladimír BALCAR, Vladimír JANOUT a Jana POVOVÁ. Diabetes, hypertension and stroke - does Alzheimer protect you? Neuroendocrinology Letters. Edition Medizin, 2014, roč. 35, č. 8, s. 691-696. ISSN 0172-780X.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Diabetes, hypertension and stroke - does Alzheimer protect you?
Autoři ŠERÝ, Omar (203 Česká republika, garant, domácí), Lýdia HLINECKÁ (203 Česká republika, domácí), Vladimír BALCAR (36 Austrálie), Vladimír JANOUT (203 Česká republika) a Jana POVOVÁ (203 Česká republika).
Vydání Neuroendocrinology Letters, Edition Medizin, 2014, 0172-780X.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30000 3. Medical and Health Sciences
Stát vydavatele Švédsko
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 0.799
Kód RIV RIV/00216224:14310/14:00080179
Organizační jednotka Přírodovědecká fakulta
UT WoS 000350360300006
Klíčová slova anglicky ApoE; hypertension; diabetes; stroke; association; polymorphism
Štítky AKR, rivok
Změnil Změnila: Ing. Andrea Mikešková, učo 137293. Změněno: 28. 4. 2015 09:57.
Anotace
OBJECTIVE: The aim of our current research project is to further evaluate the role of risk factors in the pathogenesis of Alzheimer's disease; these include genetic variations, environmental factors and lifestyle issues. METHODS: We have been conducting an association study on 373 patients with Alzheimer's disease and 286 unrelated control individuals. The occurrence and the age of onset of diabetes and cardiovascular diseases were evaluated in both groups. Apolipoprotein E genotype was analyzed in all subjects by PCR method. RESULTS: We report that, in Czech population carrying ApoE4 allele increases risk of Alzheimer's disease 2.1-fold and genotype E4E4 increases the risk 8.4-fold. We have also identified a significant association between ApoE4 allele, Alzheimer's disease and hypertension. Hypertensive subjects with the ApoE4 allele have 1.5-fold greater risk of Alzheimer's disease. Thus, hypertension together with ApoE4 allele translates into 1.5-fold higher risk of AD. The most intriguing original finding in the present study is that Alzheimer's disease patients have significantly later onset of diabetes, hypertension and stroke in comparison with control subjects. This effect was not influenced by ApoE genotype. The diabetes appeared in AD patients on average more than 10 years later than in the control subjects (p<0.0001), hypertension was diagnosed 14 years later in AD patients (p<0.00001) and stroke occurred on average 6 years later (p<0.005), compared to the control group. CONCLUSIONS: Overall, in addition to the above novel findings, our study expands the data base on risk factors that could be used in near future when testing for the genetic risk of Alzheimer's disease.
Návaznosti
NT11152, projekt VaVNázev: Epidemiologie a genetika Alzheimerovy choroby
VytisknoutZobrazeno: 6. 10. 2024 08:49